A multicenter, prospective, double-blind, randomized controlled trial (XBJ-SIC) of Xuebijing Injection for the treatment of sepsis-induced coagulopathy

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 5cdb5606813f45fcec63497d1f222e8cf56f9e5c
First added on: Apr 24, 2026